TY - JOUR T1 - Erlotinib, an Effective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces p27<sup>KIP1</sup> Upregulation and Nuclear Translocation in Association with Cell Growth Inhibition and Cell Cycle Arrest in Human Non-Small Cell Lung Cancer Cell Lines JF - Molecular Pharmacology JO - Mol Pharmacol DO - 10.1124/mol.107.034827 AU - Yi-He Ling AU - Tianhong Li AU - Ziqiang Yuan AU - Missak Haigentz, Jr AU - Thomas K Weber AU - Roman Perez-Soler Y1 - 2007/04/24 UR - http://molpharm.aspetjournals.org/content/early/2007/04/24/mol.107.034827.abstract N2 - 300 Multiple ChoicesThis is a pdf-only article and there is no markup to show you.full-text.pdf ER -